Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MitoChem Therapeutics was founded by Craig Beeson PhD and Bärbel Rohrer PhD to focus on developing treatments to address the effects of mitochondrial dysfunction in neurodegenerative diseases. Dr. Beeson, a medicinal chemist and Professor of Drug Discovery and Biomedical Sciences, and Dr. Rohrer, a neuroscientist and Professor of Ophthalmology, both at Medical University of South Carolina, combined their expertise in mitocho...
MitoChem Therapeutics was founded by Craig Beeson PhD and Bärbel Rohrer PhD to focus on developing treatments to address the effects of mitochondrial dysfunction in neurodegenerative diseases. Dr. Beeson, a medicinal chemist and Professor of Drug Discovery and Biomedical Sciences, and Dr. Rohrer, a neuroscientist and Professor of Ophthalmology, both at Medical University of South Carolina, combined their expertise in mitochondria, neuroscience and chemistry to tackle hard to treat diseases.

List your booth number for exhibitions, ask us